Table 4 Adverse Events Caused with Treatments (n (%))
Adverse Events | Section 1 | Section 2 | ||||
|---|---|---|---|---|---|---|
Liraglutide monotherapy n = 30 | Metformin monotherapy n = 30 | P | Liraglutide (1.8 mg/d) monotherapy n = 30 | Liraglutide plus Metformin dual therapy n = 30 | P | |
Transient anorexia, nausea or vomit | 5 (16.7) | 7 (23.3) | 0.519 | 6 (20.0) | 14 (46.7) | 0.029 |
Transient diarrhea | 2 (6.7) | 2 (6.7) | 1.000 | 3 (10.0) | 1 (3.3) | 0.612 |
Hypoglycemia | 1 (3.3) | 1 (3.3) | 1.000 | 4 (13.3) | 3 (10.0) | 1.000 |
Injection site skin induration and irritation | 1 (3.3) | 0 (3.3) | 0.313 | 1 (3.3) | 2 (6.7) | 1.000 |